EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Mitochondrial dysfunction, metabolic quiescence and premature senescence in CMT4B3 fibroblasts

Paola Zanfardino, Alessandro Amati, Sharon Cox, Gennaro Agrimi, Stefano Doccini, Patricio Fernández-Silva, Apollonia Tullo, Jessica Rosati, Filippo M Santorelli, Vittoria Petruzzella iD

Human Molecular Genetics · 10.08.2026 · 35 (17)

DOI: 10.1093/hmg/ddag080 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Human Molecular Genetics, online erschienen am 21.08.2026. Verfasst von Paola Zanfardino und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Translational Biomedicine and Neuroscience - DiBraiN, University of Bari Aldo Moro, Piazza Giulio Cesare 11, 70124, Bari, Italy. Hauptthemen laut MEDLINE: Fibroblasts, Charcot-Marie-Tooth Disease, Mitochondria, Cellular Senescence. Die Arbeit nennt 52 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: REGIONE PUGLIA-MALATTIE RARE-Petruzzella, CollaGe and Fondazione Opera Pia Monte di Pietà e Confidenze, Italian Ministry of Health-Ricerca Corrente.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Charcot–Marie–Tooth disease type 4B3 (CMT4B3) is an ultra-rare autosomal recessive neuropathy caused by mutations in the MTMR5/SBF1 gene. In this study, we characterized dermal fibroblasts derived from a patient carrying compound-heterozygous MTMR5/SBF1 variants (R763H/G1064E) and identified alterations affecting mitochondrial metabolism and cellular stress pathways. Patient fibroblasts exhibited fragmented mitochondrial networks with a shift toward fission, together with reduced ATP production, while mitochondrial mass, respiratory chain assembly, and markers of mitochondrial biogenesis were preserved. In line with our previous evidence of enhanced mitophagy, these findings support the presence of altered mitochondrial quality control. The reduction in cellular energy production was not accompanied by increased glycolytic activity, indicating a metabolically quiescent phenotype. Transcriptomic profiling revealed dysregulation of the PI3K/AKT signalling pathway. AKT phosphorylation at Ser473 was increased in the absence of complete canonical AKT activation. These signalling changes were associated with increased expression of p53 and p21 and with features consistent with premature cellular senescence. Overall, our findings identify metabolic quiescence and premature senescence as previously unrecognized aspects of CMT4B3 cellular pathology and suggest that altered coordination between mitochondrial metabolism and intracellular signalling may contribute to disease pathogenesis.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

FibroblastsCharcot-Marie-Tooth DiseaseMitochondriaCellular SenescenceHumansSignal TransductionPhosphatidylinositol 3-KinasesProto-Oncogene Proteins c-aktMutationTumor Suppressor Protein p53

Stichwörter der Autor:innen

Charcot–Marie–tooth disease type 4B3MTMR5/SBF1mitochondriaoxidative phosphorylationsenescencetranscriptomics

Substanzen

Phosphatidylinositol 3-KinasesProto-Oncogene Proteins c-aktTumor Suppressor Protein p53

Autor:innen und Institutionen

  • Department of Translational Biomedicine and Neuroscience - DiBraiN, University of Bari Aldo Moro, Piazza Giulio Cesare 11, 70124, Bari, Italy.
  • Department of Biosciences, Biotechnology and Environment, University of Bari Aldo Moro, Via Orabona, 70124 Bari, Italy.
  • U.O.C. Medicina Molecolare, Neurogenetica e Malattie Neuromuscolari IRCCS Fondazione Stella Maris, Viale del Tirreno, 156018 CALAMBRONE, Pisa, Italy.
  • Department Biochemistry and Molecular and Cell Biology, Faculty of Sciences, Campus San Francisco Square, Biocomputation and Complex Systems Physics Institute (BIFI), University of Zaragoza, E-50009 Zaragoza, Spain, Zar…
  • Institute of Biomembrane, Bioenergetics and Molecular Biotechnology (IBIOM) -Bari - CNR, -Via Amendola 122/D 70126, Bari, Italy.
  • Cellular Reprogramming Unit, Fondazione IRCCS Casa Sollievo della Sofferenza, 71013, San Giovanni Rotondo, Italy.

ORCID-Profile: Vittoria Petruzzella

Förderung

  • REGIONE PUGLIA-MALATTIE RARE-Petruzzella
  • CollaGe and Fondazione Opera Pia Monte di Pietà e Confidenze
  • Italian Ministry of Health-Ricerca Corrente
  • REGIONE PUGLIA—MALATTIE RARE—Petruzzella
  • Italian Ministry of Health—Ricerca Corrente

Zitieren

APA

Zanfardino, P., Amati, A., Cox, S., Agrimi, G., Doccini, S., Fernández-Silva, P., Tullo, A., Rosati, J., Santorelli, F. M., & Petruzzella, V. (2026). Mitochondrial dysfunction, metabolic quiescence and premature senescence in CMT4B3 fibroblasts. Human Molecular Genetics, 35(17). https://doi.org/10.1093/hmg/ddag080

Vancouver

Zanfardino P, Amati A, Cox S, Agrimi G, Doccini S, Fernández-Silva P, et al. Mitochondrial dysfunction, metabolic quiescence and premature senescence in CMT4B3 fibroblasts. Human Molecular Genetics. 2026;35(17). doi:10.1093/hmg/ddag080

BibTeX
@article{Zanfardino2026,
  author = {Zanfardino, Paola and Amati, Alessandro and Cox, Sharon and Agrimi, Gennaro and Doccini, Stefano and Fernández-Silva, Patricio and Tullo, Apollonia and Rosati, Jessica and Santorelli, Filippo M and Petruzzella, Vittoria},
  title = {Mitochondrial dysfunction, metabolic quiescence and premature senescence in CMT4B3 fibroblasts},
  journal = {Human Molecular Genetics},
  year = {2026},
  volume = {35},
  number = {17},
  doi = {10.1093/hmg/ddag080}
}
Kostenlos starten →